Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fusion Pharmaceuticals Inc. (FUSN) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fusion Pharmaceuticals Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1805890.
Total stock buying since 2020: $55,719,437.
Total stock sales since 2020: $1,708,358.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 44,400 | $90,131 | 214,487 | $1,604,933 | 0 | $0 |
| 2021 | 12,000 | $96,715 | 0 | $0 | 0 | $0 |
| 2020 | 3,266,623 | $55,532,591 | 8,369 | $103,425 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-08 | 44,400 | $90,131 | 0 | $0 | 0 | $0 |
| 2022-04 | 0 | $0 | 48,813 | $331,693 | 0 | $0 |
| 2022-03 | 0 | $0 | 66,123 | $487,824 | 0 | $0 |
| 2022-02 | 0 | $0 | 99,551 | $785,416 | 0 | $0 |
| 2021-08 | 12,000 | $96,715 | 0 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 8,369 | $103,425 | 0 | $0 |
| 2020-06 | 3,266,623 | $55,532,591 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-11 | Gannon Steven (Director) | Buy | 44,400 | 2.03 | 90,131 |
| 2022-04-27 | Valliant John (Chief Executive Officer) | Sale | 4,511 | 6.03 | 27,201 |
| 2022-04-26 | Valliant John (Chief Executive Officer) | Sale | 2,147 | 6.07 | 13,032 |
| 2022-04-25 | Valliant John (Chief Executive Officer) | Sale | 2,036 | 6.03 | 12,277 |
| 2022-04-21 | Valliant John (Chief Executive Officer) | Sale | 922 | 6.01 | 5,541 |
| 2022-04-20 | Valliant John (Chief Executive Officer) | Sale | 367 | 6.02 | 2,209 |
| 2022-04-13 | Valliant John (Chief Executive Officer) | Sale | 11,994 | 6.41 | 76,881 |
| 2022-04-12 | Valliant John (Chief Executive Officer) | Sale | 18,255 | 7.10 | 129,610 |
| 2022-04-11 | Valliant John (Chief Executive Officer) | Sale | 2,600 | 7.37 | 19,162 |
| 2022-04-08 | Valliant John (Chief Executive Officer) | Sale | 826 | 7.52 | 6,211 |
| 2022-04-07 | Valliant John (Chief Executive Officer) | Sale | 1,255 | 7.56 | 9,487 |
| 2022-04-06 | Valliant John (Chief Executive Officer) | Sale | 100 | 7.58 | 758 |
| 2022-04-05 | Valliant John (Chief Executive Officer) | Sale | 2,100 | 7.67 | 16,107 |
| 2022-04-04 | Valliant John (Chief Executive Officer) | Sale | 700 | 7.81 | 5,467 |
| 2022-04-01 | Valliant John (Chief Executive Officer) | Sale | 1,000 | 7.75 | 7,750 |
| 2022-03-30 | Valliant John (Chief Executive Officer) | Sale | 300 | 7.52 | 2,256 |
| 2022-03-29 | Valliant John (Chief Executive Officer) | Sale | 200 | 7.52 | 1,504 |
| 2022-03-28 | Valliant John (Chief Executive Officer) | Sale | 9,600 | 7.55 | 72,480 |
| 2022-03-25 | Valliant John (Chief Executive Officer) | Sale | 500 | 7.42 | 3,710 |
| 2022-03-23 | Valliant John (Chief Executive Officer) | Sale | 100 | 7.50 | 750 |
| 2022-03-22 | Valliant John (Chief Executive Officer) | Sale | 4,000 | 7.53 | 30,120 |
| 2022-03-21 | Valliant John (Chief Executive Officer) | Sale | 2,200 | 7.46 | 16,427 |
| 2022-03-18 | Valliant John (Chief Executive Officer) | Sale | 1,204 | 7.61 | 9,162 |
| 2022-03-17 | Valliant John (Chief Executive Officer) | Sale | 900 | 7.51 | 6,759 |
| 2022-03-16 | Valliant John (Chief Executive Officer) | Sale | 100 | 6.99 | 699 |
| 2022-03-15 | Valliant John (Chief Executive Officer) | Sale | 100 | 7.12 | 712 |
| 2022-03-14 | Valliant John (Chief Executive Officer) | Sale | 1,300 | 6.96 | 9,048 |
| 2022-03-11 | Valliant John (Chief Executive Officer) | Sale | 100 | 7.13 | 713 |
| 2022-03-10 | Valliant John (Chief Executive Officer) | Sale | 1,900 | 7.06 | 13,414 |
| 2022-03-09 | Valliant John (Chief Executive Officer) | Sale | 822 | 6.94 | 5,704 |
| 2022-03-08 | Valliant John (Chief Executive Officer) | Sale | 3,004 | 6.92 | 20,787 |
| 2022-03-07 | Valliant John (Chief Executive Officer) | Sale | 3,100 | 6.99 | 21,669 |
| 2022-03-04 | Valliant John (Chief Executive Officer) | Sale | 8,400 | 7.32 | 61,488 |
| 2022-03-03 | Valliant John (Chief Executive Officer) | Sale | 200 | 7.28 | 1,456 |
| 2022-03-02 | Valliant John (Chief Executive Officer) | Sale | 26,546 | 7.44 | 197,502 |
| 2022-03-01 | Valliant John (Chief Executive Officer) | Sale | 847 | 7.37 | 6,242 |
| 2022-02-28 | Valliant John (Chief Executive Officer) | Sale | 3,100 | 7.40 | 22,940 |
| 2022-02-25 | Valliant John (Chief Executive Officer) | Sale | 8,152 | 7.57 | 61,710 |
| 2022-02-24 | Valliant John (Chief Executive Officer) | Sale | 2,500 | 7.41 | 18,525 |
| 2022-02-23 | Valliant John (Chief Executive Officer) | Sale | 29,299 | 7.77 | 227,653 |
| 2022-02-22 | Valliant John (Chief Executive Officer) | Sale | 4,100 | 7.85 | 32,185 |
| 2022-02-18 | Valliant John (Chief Executive Officer) | Sale | 4,898 | 7.88 | 38,596 |
| 2022-02-17 | Valliant John (Chief Executive Officer) | Sale | 1,700 | 7.98 | 13,566 |
| 2022-02-16 | Valliant John (Chief Executive Officer) | Sale | 33,202 | 7.99 | 265,283 |
| 2022-02-15 | Valliant John (Chief Executive Officer) | Sale | 12,600 | 8.33 | 104,958 |
| 2021-08-23 | Gannon Steven (Director) | Buy | 2,829 | 7.99 | 22,589 |
| 2021-08-19 | Gannon Steven (Director) | Buy | 3,000 | 8.05 | 24,150 |
| 2021-08-18 | Gannon Steven (Director) | Buy | 171 | 8.05 | 1,376 |
| 2021-08-16 | Gannon Steven (Director) | Buy | 6,000 | 8.10 | 48,600 |
| 2020-12-24 | Adams Street Partners Llc | Sale | 3,800 | 12.32 | 46,816 |
| 2020-12-23 | Adams Street Partners Llc | Sale | 4,569 | 12.39 | 56,609 |
| 2020-06-30 | Healthcap Vii Gp S.a. (10% Owner) | Buy | 240,000 | 17.00 | 4,080,000 |
| 2020-06-30 | Khuong Chau Quang (Director) | Buy | 898,000 | 17.00 | 15,266,000 |
| 2020-06-30 | Preston Heather (Director) | Buy | 8,823 | 17.00 | 149,991 |
| 2020-06-30 | Crowley John J (Chief Financial Officer) | Buy | 6,500 | 17.00 | 110,500 |
| 2020-06-30 | Christenson Johan (Director) | Buy | 240,000 | 17.00 | 4,080,000 |
| 2020-06-30 | O'leary James J (Chief Medical Officer) | Buy | 300 | 17.00 | 5,100 |
| 2020-06-30 | Orbimed Capital Llc (Director) | Buy | 898,000 | 17.00 | 15,266,000 |
| 2020-06-30 | Coulter James G | Buy | 250,000 | 17.00 | 4,250,000 |
| 2020-06-30 | Johnson & Johnson Innovation - Jjdc, Inc. | Buy | 725,000 | 17.00 | 12,325,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of FUSN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fusion Pharmaceuticals Inc. (symbol FUSN, CIK number 1805890) see the Securities and Exchange Commission (SEC) website.